The aim of the conference is to harness cross-disciplinary and cross-disease learning to accelerate drug discovery and reduce drug candidate attrition rates for infectious diseases affecting low and middle income countries.
The current situation
Date: Sunday, 12 May 2019
The global situation
Clinical development and connectivity to the preclinical situation
Date: Monday, 13 May 2019
Clinical trials for Chagas Disease. Understanding clinical PK/PD relationships. How can we do trials for Chagas disease better?
New start points & targets
Date: Wednesday, 15 May 2019
New leads for Chagas disease and leishmaniasis from the Lead Optimization Latin America (LOLA) Consortium
Development of chemical probes and on-target cellular assays to enable Aminoacyl-tRNA Synthetases as targets for drug discovery against leishmaniasis